Diagnostic Cytopathology · 1996 · 28 citations · 30 references
MedicineGynecologyOncologyCytopathologyEndocrine OncologyGynecologic OncologyBreast CytologyImmunohistochemistryOvarian CancerStaining TechniquesTumor CytopathologyTumor MarkersCell Block TechniqueEstrogen Receptor ExpressionEstrogen Receptor StatusFormalin-fixed Paraffin-embedded Tissue AnalysisParaffin-embedded Tissue StainingProgesterone Receptor ExpressionProgesterone Receptor StatusProgesterone Receptors
Estrogen and progesterone receptor reactivity may be useful in identifying possible primary sites of metastatic disease or directing therapy in tumors of the female genital tract, including breast, ovary, and endometrium. Various methods have been described for the immunocytochemical evaluation of estrogen receptor (ER) and progesterone receptor (PR) status of cytologic specimens but our results have been variable. We evaluated the effectiveness of various fixatives [cytospin collection fluid, Shandon, Pittsburgh, PA (SH); ethanol (ETH); and formalin (FOR)] for fixation of smears (SM) and cell block (CB) material. The percentage and intensity of tumor nuclei of SM, CB, and tissue sections (TS) stained for ER and PR by the avidin-biotin-peroxidase complex technique were compared. Samples were considered ER or PR positive when > or = 20% of tumor nuclei were stained. The sensitivity of ER analysis of SMs and CBs in each fixative compared to formalin-fixed paraffin-embedded tissue sections were as follows: SM (SH) 88%, SM (ETH) 14%, CB (SH) 58%, CB (ETH) 43%, and CB (FOR) 70%. The sensitivity of PR determination on SMs and CBs was SM (SH) 71%, SM (ETH) 6.0%, CB (SH) 25%, CB (ETH) 33%, CB (FOR) 80%. These findings indicate that of the fixatives evaluated for ER analysis, SMs fixed in SH provided the best results. For PR evaluation, CBs fixed in FOR gave the best results.
30
The value of estrogen and progesterone receptors in the treatment of breast cancer
C. Kent Osborne, Michael G. Yochmowitz, William A. Knight et al. · Cancer · 1980 · 725 citations · Full text
Medicine, Endocrinology, Oncology +17
Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer.
William A. Knight, Robert B. Livingston, E Gregory et al. · PubMed · 1977 · 706 citations
Medicine, Endocrinology, Oncology +16
Stanley J. Robbo · Human Pathology · 1991 · 381 citations
Molecular Biology of the Human T-Lymphotropic Retroviruses
Flossie Wong‐Staal · 1986 · 318 citations